← Back to Search

CV Care Program for Prostate Cancer

N/A

Waitlist Available

Led By Alicia Morgans, MD, MPH

Research Sponsored by Dana-Farber Cancer Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥18 years.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 months (from 4 weeks after adt initiation to the week 24 on-treatment visit)

Awards & highlights

Study Summary

This trial is testing a program to assess and manage cardiovascular risk factors in prostate cancer patients starting hormone therapy. The goal is to create a standardized method for all patients at the Dana-Farber Cancer Institute

Who is the study for?

This trial is for individuals with prostate cancer who are beginning androgen deprivation therapy (ADT). It aims to help manage cardiovascular risks that may arise from their cancer treatment. Participants should be starting ADT soon or have started it recently.Check my eligibility

What is being tested?

The study is testing a 'CV Care Program' designed to assess and manage heart health risks in patients undergoing ADT for prostate cancer. The goal is to see if this program can become a standard part of patient care at the Dana-Farber Cancer Institute.See study design

What are the potential side effects?

Since the intervention involves assessment and management rather than medication, direct side effects are not expected as typically seen with drug trials. However, any changes made to manage CV risk could potentially have their own effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 months (from 4 weeks after adt initiation to the week 24 on-treatment visit)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 months (from 4 weeks after adt initiation to the week 24 on-treatment visit)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 months (from 4 weeks after adt initiation to the week 24 on-treatment visit) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Participant Retention Rate in CV CARE 2

Secondary outcome measures

Proportion of Participants on Blood Pressure Medications in CV CARE

Proportion of Participants on Blood Pressure Medications in CV CARE 2

Proportion of Participants on Statin Medications in CV CARE

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: CV Care Program 2Experimental Treatment1 Intervention

Study procedures will be conducted as follows: Standard of care androgen deprivation therapy. 4 week standard-of-care follow up visit in clinic with CV care education module completion. 12-week standard-of-care prostate cancer care visit with oncologist. 24-week standard-of-care post-ADT visit in clinic with CV Care module completion, surveys, and exit interview with clinical team members. Participant feedback from surveys, exit-interviews, and possibly focus groups will be collected.

Group II: CV Care ProgramExperimental Treatment1 Intervention

Study procedures will be conducted as follows: Standard of care androgen deprivation therapy. 4 week standard-of-care follow up visit in clinic with CV care education module completion. 12-week standard-of-care prostate cancer care visit with oncologist. 24-week standard-of-care post-ADT visit in clinic with CV Care module completion, surveys, and exit interview with clinical team members. The CV Care program will be revised through participant feedback from assessments, surveys, focus groups, and exit-interviews. The revised CV Care Program will be used in the next cohort.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Comprehensive Cancer NetworkNETWORK

115 Previous Clinical Trials

7,455 Total Patients Enrolled

5 Trials studying Prostate Cancer

221 Patients Enrolled for Prostate Cancer

Dana-Farber Cancer InstituteLead Sponsor

1,079 Previous Clinical Trials

340,797 Total Patients Enrolled

76 Trials studying Prostate Cancer

15,925 Patients Enrolled for Prostate Cancer

Alicia Morgans, MD, MPHPrincipal InvestigatorDana-Farber Cancer Institute

1 Previous Clinical Trials

57 Total Patients Enrolled

1 Trials studying Prostate Cancer

57 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available positions for patients to participate in this clinical trial?

"According to the information available on clinicaltrials.gov, this particular study is no longer actively recruiting patients. The trial was initially posted on June 1st, 2024 and its last update was made on January 1st, 2024. However, it's worth noting that there are currently 1737 other ongoing clinical trials actively seeking participants at this time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

CV CARE: CardioVascular Care in PC Patients

Alicia Morgans 2024. "CV CARE: CardioVascular Care in PC Patients". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06202820.